openPR Logo
Press release

Global Fibrosarcoma Market Outlook and Market Development Analysis Reveals Forecast for the Period 2017-2026

04-09-2018 11:29 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

The global market discussion on “Fibrosarcoma” can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Fibrosarcoma Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2026”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on global fibrosarcoma market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=353

According to a study by Fact.MR, the global fibrosarcoma market is expected to witness steady growth. The market is likely to register CAGR of 5.5% during the forecast period 2017-2026. The global fibrosarcoma market is also projected to bring in US$ 442.4 million revenue. Fibrosarcoma is increasingly rare as a diagnosis compared to other sarcoma subtypes. Some of the sarcomas are sensitive to chemotherapy, hence ongoing attempts are being done to intensify chemotherapy. However, fibrosarcoma that does not respond to chemotherapy, needs to be treated with other methods but might lead to some side-effects. This is driving the development of new therapies with potential benefits. Below insights show how the global fibrosarcoma market will perform in the coming years. 

5 Forecast Highlights on Global Fibrosarcoma Market

1- North America is expected to remain dominant in the global fibrosarcoma market during the forecast period 2017-2026. Well-developed healthcare infrastructure in North America is one of the factors boosting the growth of fibrosarcoma treatment in the region. Technological advancement is also resulting in the development of advanced cancer treatment drugs. Moreover, increasing population suffering from diabetes, overweight and depression are also leading towards high possibilities of cancer.  

2- Europe and Asia Pacific Excluding Japan (APEJ) are also expected to witness growth in the diagnoses and treatment of fibrosarcoma due to the increasing investments in the research and development activities for treatment of various cancers.

3- Chemotherapy is expected to be the most preferred treatment for fibrosarcoma. By the end of 2026, chemotherapy is projected to reach close to US$ 200 million revenue.

4- Hospitals are expected to be the largest end-users in the global fibrosarcoma market. Hospitals are projected to reach nearly US$ 200 million revenue by the end of 2026.

5- Among various distribution channels, hospital pharmacy is expected to emerge as the largest distribution channel during the forecast period 2017-2026. Accounting for nearly half of the revenue share, hospital pharmacies are projected to exceed US$ 100 million revenue towards the end of 2026.

Browse Full Report With TOC- https://www.factmr.com/report/353/fibrosarcoma-market

Table of Content

Global Economic Outlook
Global Fibrosarcoma Market - Executive Summary
Global Fibrosarcoma Market Overview
3.1. Introduction
       3.1.1. Global Fibrosarcoma Market Taxonomy
       3.1.2. Global Fibrosarcoma Market Definition
3.2. Global Fibrosarcoma Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Fibrosarcoma Market Y-o-Y Growth
3.3. Global Fibrosarcoma Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Drug Pipeline Assessment
3.8. PESTL Analysis
3.9. Product Life Cycle
Global Fibrosarcoma Market Analysis and Forecast 2012-2026 
4.1. Global Fibrosarcoma Market Size and Forecast By Treatment Type, 2012-2026
       4.1.1. Chemotherapy Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Radiation Therapy Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Surgery Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
Continued@@@...

Check For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=353

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/ 
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Fibrosarcoma Market Outlook and Market Development Analysis Reveals Forecast for the Period 2017-2026 here

News-ID: 1007468 • Views: 129

More Releases from Fact.MR

11-09-2020 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel

All 5 Releases


More Releases for Fibrosarcoma

04-19-2018 | Health & Medicine
Fact.MR
Fibrosarcoma Market: Hospital Pharmacies to Generate Significant Revenues Throug …
Undertaking radiotherapy for the treatment of malignant tumor has led to prevalence of fibrosarcoma among cancer patients. Fibrosarcoma is a rare malignant tumor that is generally treated by conducting radiation treatments and chemotherapy. As there are very few treatment procedures for fibrosarcoma, research and healthcare institutions are investing in research and development to develop effective treatment techniques. In addition, leading research institutes are focusing on developing targeted therapies that targets
Fibrosarcoma - Pipeline by BeiGene Ltd, Cell Medica Ltd, Eli Lilly and Co, and K …
Fibrosarcoma Overview                 Fibrosarcoma is a malignant tumor derived from fibrous connective tissue. Symptoms include local pain, local swelling, local warmth, dilated blood vessels pain and swelling of the bone, pathological fractures, neurological and vascular changes. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3010392-fibrosarcoma-pipeline-review-h1-2018   Major Key Players: AntiCancer Inc Cellestia Biotech AG Elsalys Biotech SAS Ignyta Inc Intezyne Technologies Inc Loxo Oncology Inc Fibrosarcoma Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Fibrosarcoma    - Pipeline Review, H1 2018, provides comprehensive information on the
Fibrosarcoma - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Fibrosarcoma - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Fibrosarcoma Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma - Pipeline Review, H1 2018, provides an overview of the Fibrosarcoma (Oncology) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581047 Fibrosarcoma is a malignant tumor derived from fibrous connective tissue.
Research Focused On the Fibrosarcoma treatment Market Size & Share, Growth, Tren …
The report "Fibrosarcoma treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025 ", has been prepared based on an in-depth market analysis with inputs from industry experts. The objectives of this study are as follows: To define, describe, and forecast the "Fibrosarcoma treatment" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities,
Fibrosarcoma treatment Market Estimated To Flourish By 2025
Sarcoma is referred to as a type of cancer that originates from the mesenchymal transformed cells. Fibrosarcoma is a rare malignancy, which is characterized by anaplastic undifferentiated spindle cells or proliferating immature fibroblasts in a storiform appearance. The disease arises from the fibrous tissue of bones such as the tibia, the femur, or the mandible. The tumor may be categorized based on differentiation degree into low-grade malignancy, intermediate malignancy, and
Fibrosarcoma - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Fibrosarcoma - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma - Pipeline Review, H2 2017, provides an overview of the Fibrosarcoma (Oncology) pipeline landscape. Fibrosarcoma is a malignant tumor derived from fibrous connective tissue. Symptoms include local pain, local swelling, local warmth, dilated blood vessels pain